We are live on ! Find out more
CNB

Camden National Bank Portfolio holdings

AUM $767M
1-Year Est. Return 14.32%
This Fund
S&P 500
This Quarter Est. Return
+1.2%
1 Year Est. Return
+14.32%
3 Year Est. Return
+48.76%
5 Year Est. Return
+65.18%
10 Year Est. Return
AUM
$648M
AUM Growth
+$81.4M
Cap. Flow
+$78.3M
Cap. Flow %
12.09%
Top 10 Hldgs %
25.12%
Holding
133
New
11
Increased
92
Reduced
16
Closed

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$5.01M
2
ACN icon
Accenture
ACN
+$3.25M
3
MSFT icon
Microsoft
MSFT
+$3.12M
4
CVX icon
Chevron
CVX
+$2.75M
5
JNJ icon
Johnson & Johnson
JNJ
+$2.71M

Sector Composition

Rank Sector Weight
1 Technology 17.06%
2 Healthcare 14.95%
3 Consumer Staples 12.01%
4 Industrials 10.59%
5 Financials 9.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TROW icon
51
T. Rowe Price
TROW
$24.4B
$5.85M 0.9%
50,755
+6,622
+15% +$762K
EXPD icon
52
Expeditors International
EXPD
$23.3B
$5.77M 0.89%
46,210
+5,249
+13% +$625K
TMO icon
53
Thermo Fisher Scientific
TMO
$220B
$5.65M 0.87%
10,210
+1,126
+12% +$645K
USMV icon
54
iShares MSCI USA Min Vol Factor ETF
USMV
$24.5B
$5.51M 0.85%
65,626
+6,652
+11% +$548K
NKE icon
55
Nike
NKE
$62.2B
$4.06M 0.63%
+53,919
New +$5.01M
AAPL icon
56
Apple
AAPL
$4.46T
$3.59M 0.55%
17,026
+333
+2% +$62.1K
IAU icon
57
iShares Gold Trust
IAU
$64.5B
$3.53M 0.54%
80,250
+4,134
+5% +$183K
CAC icon
58
Camden National
CAC
$964M
$3.45M 0.53%
104,464
+11,598
+12% +$366K
IJH icon
59
iShares Core S&P Mid-Cap ETF
IJH
$127B
$3.35M 0.52%
57,301
+7,844
+16% +$461K
IEI icon
60
iShares 3-7 Year Treasury Bond ETF
IEI
$17.7B
$3.28M 0.51%
28,366
+2,047
+8% +$235K
ELV icon
61
Elevance Health
ELV
$86.1B
$3.01M 0.46%
5,551
+674
+14% +$356K
USB icon
62
US Bancorp
USB
$99.8B
$2.7M 0.42%
68,082
+9,100
+15% +$371K
TFC icon
63
Truist Financial
TFC
$63.4B
$2.67M 0.41%
68,829
+9,462
+16% +$357K
SNA icon
64
Snap-on
SNA
$21.3B
$2.62M 0.41%
10,040
+1,217
+14% +$334K
SCHD icon
65
Schwab US Dividend Equity ETF
SCHD
$107B
$2.62M 0.4%
101,088
-258
-0.3% -$6.72K
BRK.B icon
66
Berkshire Hathaway Class B
BRK.B
$1.15T
$2.3M 0.36%
5,662
+1,955
+53% +$799K
LQD icon
67
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.7B
$2.11M 0.33%
19,718
+2,828
+17% +$302K
EMXC icon
68
iShares MSCI Emerging Markets ex China ETF
EMXC
$23.8B
$1.9M 0.29%
32,085
+5,365
+20% +$309K
GOOGL icon
69
Alphabet (Google) Class A
GOOGL
$4.33T
$1.79M 0.28%
9,828
+3,977
+68% +$670K
ABBV icon
70
AbbVie
ABBV
$434B
$1.71M 0.26%
9,986
+1,985
+25% +$329K
HON icon
71
Honeywell
HON
$77.2B
$1.5M 0.23%
7,458
+1,176
+19% +$224K
LLY icon
72
Eli Lilly
LLY
$1.08T
$1.49M 0.23%
1,645
+7
+0.4% +$5.6K
IVV icon
73
iShares Core S&P 500 ETF
IVV
$904B
$1.41M 0.22%
2,580
-12
-0.5% -$6.31K
WMT icon
74
Walmart Inc
WMT
$889B
$1.35M 0.21%
19,990
+5,522
+38% +$348K
XOM icon
75
ExxonMobil
XOM
$657B
$1.34M 0.21%
11,671
+2,707
+30% +$315K

Similar funds

Camden National Bank's Q2 2024 Portfolio in Review

As of Q2 2024, Camden National Bank held 133 positions worth $648M, up 14% from $566M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Camden National Bank deployed $78.3M of net new capital in Q2 2024, opening 11 new positions and adding to 92 existing holdings. Its largest new stake was Nike: 53,919 shares worth $4.06M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was BCE, an estimated $4.1M trimmed.

  • Camden National Bank's largest Q2 2024 buy was Nike: 53,919 shares worth $4.06M.
  • Camden National Bank added most to Accenture in Q2 2024, an estimated $3.25M increase.
  • Camden National Bank's biggest Q2 2024 reduction was BCE, cutting an estimated $4.1M.
  • Camden National Bank's ten largest holdings make up 25% of its $648M portfolio in Q2 2024.
  • Camden National Bank opened 11 new positions and closed 0 in Q2 2024.
  • Camden National Bank's portfolio value rose 14% quarter-over-quarter to $648M.

Based on Camden National Bank's 13F filing for Q2 2024, filed 13 Aug 2024.